by gopharmazie | May 12, 2025 | Regulatory
In the pharmaceutical industry, having timely and accurate reimbursement data is crucial for successful market access across Europe. Especially in Germany, Austria, and Switzerland (DACH), you face a patchwork of pricing systems and databases. Navigating these can be...
by gopharmazie | May 12, 2025 | Regulatory
Germany has been grappling with increasing medicine shortages in recent years. Ensuring a reliable drug shortage database in Germany is crucial for healthcare stakeholders to maintain patient care and plan effectively. Official figures show that medicine supply issues...
by gopharmazie | Feb 14, 2019 | Drug Dictionaries, Drug Pricing, Drug Safety, Most popular, News-Updates, Regulatory
The new Falsified Medicines Directive 2019 – which medicines are affected? As of 9. February 2019, the Falsified Medicines Directive (2011/62/EU), which was adopted in 2011, has officially come into force. What does this mean for the affected players such as...
